MRI and Clinical Predictive Factors of the Response to Arthrographic Distension in Severe Capsulitis

CompletedOBSERVATIONAL
Enrollment

55

Participants

Timeline

Start Date

October 9, 2020

Primary Completion Date

October 21, 2022

Study Completion Date

November 14, 2022

Conditions
Adhesive Capsulitis
Interventions
OTHER

Arthrographic distension

"The treatment consists in one to three shoulder joint capsule arthrographic distension. It consists after local anesthesia, in an injection under pressure of xylocaine 1% and physiological serum in the glenohumeral joint associated with an ampoule of corticosteroids (Betamethasone or Triamcinolone hexacetonide ) at the end of the operation.~* first arthrographic distension is performed under scopic guidance~* second and/or third arthrographic distension are performed under ultrasound guidance"

OTHER

Immediate joint mobilization

"This procedure was associated with intensive (immediate mobilization, recovery of maximum amplitudes by the physiotherapist and on arthro-motor).~Physical treatment aimed at rapid amplitude gain and is started immediately after the arthrographic distension, under the effect of local anesthesia. It is at best continued daily at a rate of 2 to 8 hours per day for one to 2 weeks. Depending on the effect obtained on pain and the daily progression of rehabilitation, arthrographic distension may be repeated once or twice during the mobilization period."

Trial Locations (1)

75014

Service de Rééducation et de Réadaptation de l'Appareil Locomoteur et des Pathologies du Rachis, Paris

All Listed Sponsors
collaborator

URC-CIC Paris Descartes Necker Cochin

OTHER

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT04653636 - MRI and Clinical Predictive Factors of the Response to Arthrographic Distension in Severe Capsulitis | Biotech Hunter | Biotech Hunter